Entering text into the input field will update the search result below

First patient enrolled in China Oncology's late-stage socazolimab lung cancer trial

  • China Oncology Focus has enrolled the first patient in China in the late-stage trial of socazolimab combined with chemotherapy in the first-line treatment of extensive-stage small-cell lung cancer ((ES-SCLC)).
  • China Oncology had received exclusive rights to develop and commercialize the antibody for Greater

Recommended For You

About SRNEQ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SRNEQ--
Sorrento Therapeutics, Inc.